MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Fast-acting insulins are designed to mimic the normal physiologic insulin response that occurs after meals and – if approved – Lilly's drug will compete most closely with Novo Nordisk's Fiasp ...